Literature DB >> 29605436

The role of ZA channel water-mediated interactions in the design of bromodomain-selective BET inhibitors.

Nagakumar Bharatham1, Peter J Slavish1, William R Shadrick1, Brandon M Young1, Anang A Shelat2.   

Abstract

The Bromodomain and Extra-Terminal domain (BET) family of proteins are involved in the regulation of gene transcription, and their dysregulation is implicated in several diseases including cancer. BET proteins contain two tandem bromodomains (BD1 and BD2) that independently recognize acetylated-lysine residues and appear to have distinct biological roles. We compared several published co-crystal structures and found five positions near the substrate binding pocket that vary between BET bromodomains. One position located in the ZA loop has unique properties. In BRD2-4, this residue is glutamine in BD1 and lysine in BD2; in BRDT, this residue is arginine in BD1 and asparagine in BD2. Using molecular modeling, we identified differences in the water-mediated network at this position between bromodomains. Molecular dynamics simulations helped rationalize the observed bromodomain selectivity for exemplar BET inhibitors and a congeneric series of tetrahydroquinolines (THQ) that differed by a single heteroatom near the ZA channel. The 2-furan SJ830599, the most BD2-selective THQ analog, did not disrupt the water-mediated networks in either domain, but was electrostatically-repulsed by the specific arrangement of the W5 water dipole in BD1. Our work underscores the value of exploring water-mediated interactions to study ligand binding, and highlights the difficulty of optimizing polar interactions due to high desolvation penalties. Finally, we suggest further modifications to THQ-based BET inhibitors that would increase BD2-selectivity in BRD2-4, while minimizing affinity for one or both bromodomains of BRDT.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29605436      PMCID: PMC6524770          DOI: 10.1016/j.jmgm.2018.03.005

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  40 in total

1.  Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules.

Authors:  Donald Hamelberg; John Mongan; J Andrew McCammon
Journal:  J Chem Phys       Date:  2004-06-22       Impact factor: 3.488

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Drug-like bioactive structures and conformational coverage with the LigPrep/ConfGen suite: comparison to programs MOE and catalyst.

Authors:  I-Jen Chen; Nicolas Foloppe
Journal:  J Chem Inf Model       Date:  2010-05-24       Impact factor: 4.956

4.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

5.  The generalized Born/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area.

Authors:  Paul Labute
Journal:  J Comput Chem       Date:  2008-07-30       Impact factor: 3.376

6.  Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.

Authors:  Olivier Mirguet; Romain Gosmini; Jérôme Toum; Catherine A Clément; Mélanie Barnathan; Jean-Marie Brusq; Jacqueline E Mordaunt; Richard M Grimes; Miriam Crowe; Olivier Pineau; Myriam Ajakane; Alain Daugan; Phillip Jeffrey; Leanne Cutler; Andrea C Haynes; Nicholas N Smithers; Chun-wa Chung; Paul Bamborough; Iain J Uings; Antonia Lewis; Jason Witherington; Nigel Parr; Rab K Prinjha; Edwige Nicodème
Journal:  J Med Chem       Date:  2013-09-25       Impact factor: 7.446

7.  Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain.

Authors:  Takashi Umehara; Yoshihiro Nakamura; Moon Kyoo Jang; Kazumi Nakano; Akiko Tanaka; Keiko Ozato; Balasundaram Padmanabhan; Shigeyuki Yokoyama
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

8.  The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor.

Authors:  Romain Gosmini; Van Loc Nguyen; Jérôme Toum; Christophe Simon; Jean-Marie G Brusq; Gael Krysa; Olivier Mirguet; Alizon M Riou-Eymard; Eric V Boursier; Lionel Trottet; Paul Bamborough; Hugh Clark; Chun-wa Chung; Leanne Cutler; Emmanuel H Demont; Rejbinder Kaur; Antonia J Lewis; Mark B Schilling; Peter E Soden; Simon Taylor; Ann L Walker; Matthew D Walker; Rab K Prinjha; Edwige Nicodème
Journal:  J Med Chem       Date:  2014-09-24       Impact factor: 7.446

9.  Chemical biology. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes.

Authors:  Matthias G J Baud; Enrique Lin-Shiao; Teresa Cardote; Cynthia Tallant; Annica Pschibul; Kwok-Ho Chan; Michael Zengerle; Jordi R Garcia; Terence T-L Kwan; Fleur M Ferguson; Alessio Ciulli
Journal:  Science       Date:  2014-10-16       Impact factor: 47.728

10.  Selective inhibition of BET bromodomains.

Authors:  Panagis Filippakopoulos; Jun Qi; Sarah Picaud; Yao Shen; William B Smith; Oleg Fedorov; Elizabeth M Morse; Tracey Keates; Tyler T Hickman; Ildiko Felletar; Martin Philpott; Shonagh Munro; Michael R McKeown; Yuchuan Wang; Amanda L Christie; Nathan West; Michael J Cameron; Brian Schwartz; Tom D Heightman; Nicholas La Thangue; Christopher A French; Olaf Wiest; Andrew L Kung; Stefan Knapp; James E Bradner
Journal:  Nature       Date:  2010-09-24       Impact factor: 49.962

View more
  7 in total

Review 1.  Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives.

Authors:  Lu Feng; Guan Wang; Yi Chen; Gu He; Bo Liu; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  Med Res Rev       Date:  2021-10-11       Impact factor: 12.944

2.  Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor.

Authors:  Anand Divakaran; Siva K Talluri; Alex M Ayoub; Neeraj K Mishra; Huarui Cui; John C Widen; Norbert Berndt; Jin-Yi Zhu; Angela S Carlson; Joseph J Topczewski; Ernst K Schonbrunn; Daniel A Harki; William C K Pomerantz
Journal:  J Med Chem       Date:  2018-10-16       Impact factor: 7.446

3.  Selective N-Terminal BET Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement*.

Authors:  Huarui Cui; Anand Divakaran; Anil K Pandey; Jorden A Johnson; Huda Zahid; Zachariah J Hoell; Mikael O Ellingson; Ke Shi; Hideki Aihara; Daniel A Harki; William C K Pomerantz
Journal:  Angew Chem Int Ed Engl       Date:  2020-11-18       Impact factor: 15.336

4.  Discovery of a hidden transient state in all bromodomain families.

Authors:  Lluís Raich; Katharina Meier; Judith Günther; Clara D Christ; Frank Noé; Simon Olsson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

5.  Binding selectivity of inhibitors toward the first over the second bromodomain of BRD4: theoretical insights from free energy calculations and multiple short molecular dynamics simulations.

Authors:  Yan Wang; Shiliang Wu; Lifei Wang; Zhiyong Yang; Juan Zhao; Lulu Zhang
Journal:  RSC Adv       Date:  2020-12-24       Impact factor: 3.361

6.  Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer.

Authors:  P Jake Slavish; Liying Chi; Mi-Kyung Yun; Lyudmila Tsurkan; Nancy E Martinez; Barbara Jonchere; Sergio C Chai; Michele Connelly; M Brett Waddell; Sourav Das; Geoffrey Neale; Zhenmei Li; William R Shadrick; Rachelle R Olsen; Kevin W Freeman; Jonathan A Low; Jeanine E Price; Brandon M Young; Nagakumar Bharatham; Vincent A Boyd; Jun Yang; Richard E Lee; Marie Morfouace; Martine F Roussel; Taosheng Chen; Daniel Savic; R Kiplin Guy; Stephen W White; Anang A Shelat; Philip M Potter
Journal:  Cancer Res       Date:  2020-07-10       Impact factor: 12.701

7.  Flavonoids as Putative Epi-Modulators: Insight into Their Binding Mode with BRD4 Bromodomains Using Molecular Docking and Dynamics.

Authors:  Fernando D Prieto-Martínez; José L Medina-Franco
Journal:  Biomolecules       Date:  2018-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.